BEDDINGFIELD III FREDERICK (President & CEO) purchased 5.1% of their position (40K shares) of SIENNA BIOPHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $100.0K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/26/2019ACC: 0001562180-19-001422
DirectorOfficer· President & CEO
Since Jan 2019
+40K
Net shares
Net buyer
$100.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
40K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+40K
Price / share
$2.50
Trade value
$100K
% of position
5.1%
2/22/2019
791.66K→831.66K
Total
Net shares
+40K
Net value
$100K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/22/2019 | P · Purchase | +40K | $2.50 | $100K | 5.1% | 791.66K | 831.66K |
| Total | +40K | $100K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned112.61K
Total
112.61K indirect112.61K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 112.61K | Indirect |
| Total | 112.61K | 112.61K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported